• Home
  • Leadership
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Therapeutic Programs
  • Media
  • Contact
GeneVentiv Therapeutics Wins KickStart Commercialization Grant

GeneVentiv Therapeutics Wins KickStart Commercialization Grant

by Damon Race | Mar 17, 2022 | In the News

Shar March 16, 2022 By Shellie Edge KickStart Venture Services – the premier life sciences startup program and accelerator from Innovate Carolina – has awarded commercialization grants to two UNC-affiliated startup companies, Elipsys, LLC, and GeneVentiv Therapeutics,...
GeneVentiv Therapeutics selected to pitch at CED’s Venture Connect

GeneVentiv Therapeutics selected to pitch at CED’s Venture Connect

by Damon Race | Mar 8, 2022 | In the News

Startup Spotlight: Presenting companies to pitch at CED’s Venture...

Recent Posts

  • GeneVentiv Expands Management Team and Board of Directors
  • UNC-Chapel Hill gene therapy spinout raises $1.4 million
  • Bootstrapped UNC spinout lands $300K for gene therapy work
  • Triangle gene therapy startup GeneVentiv Therapeutics awarded $250K loan from NC Biotech Center
  • GeneVentiv Therapeutics Receives Funding from the North Carolina Biotechnology Center

Recent Comments

    Archives

    • January 2023
    • September 2022
    • June 2022
    • March 2022
    • February 2022
    • November 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020

    Categories

    • In the News
    • Press

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Contact Us

    • Please prove you are human by selecting the Heart.
    • This field is for validation purposes and should be left unchanged.

    Copyright © 2020 GeneVentiv Therapeutics. All rights reserved.